Real-world effectiveness of pembrolizumab among patients with TMB-H advanced solid tumors (MK-3475-G34)

First published 06/05/2025

Last updated 04/11/2026

EU PAS number:

EUPAS1000000542

Study

Ongoing

Download as PDF

Documents

Study protocol

No information provided.

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

Real-world effectiveness of pembrolizumab among patients with TMB-H advanced solid tumors (MK-3475-G34)

Secondary tabs

Share this page